The stock has demonstrated exceptionally strong momentum over the observed period. From a closing price of $18.44 on October 2, 2025, it surged to $35.90 by March 31, 2026, representing a gain of over 94% in six months. This uptrend has been particularly sharp in recent months, with the price more than doubling from its level near $18 in early November 2025. Short-term performance has been explosive. The stock gained 33.16% over the past month, dramatically outperforming the S&P 500, which fell 5.25% over the same period. Over the last three months, the stock is up 80.67%, again massively outperforming the broader market's decline of 4.63%. The current price of $35.90 is near the top of its 52-week range of $7.68 to $36.94, trading just 2.8% below the yearly high. This positioning indicates the stock is in a strong uptrend and testing recent resistance levels after a significant rally.

Revenue and profitability have been volatile on a quarterly basis. For Q4 2025, revenue was $1.04 billion, showing 9.4% year-over-year growth from Q4 2024. However, the company reported a net loss of $37.3 million for the quarter, with a gross profit margin of -0.3%, a significant deterioration from the positive 34.7% gross margin achieved in Q3 2025. This indicates substantial quarter-to-quarter volatility in operational performance. Financial health shows a mixed picture. The company has a current ratio of 1.02, indicating barely sufficient short-term liquidity. The debt-to-equity ratio is negative at -0.52, which is an unusual situation typically arising from accumulated deficits. On a positive note, trailing twelve-month free cash flow is positive at $56.6 million. Operational efficiency metrics are weak. Return on equity (ROE) stands at 4.6%, which is modest. The negative net income for the latest quarter resulted in a negative net margin of -3.6%, highlighting current profitability challenges despite the company's revenue scale.